Condition
Eclampsia Preeclampsia
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 3 (1)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07220902Phase 3Not Yet Recruiting
Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure
NCT03143647CompletedPrimary
Magnesium and Platelet Function Testing
NCT05199558UnknownPrimary
Improved Characterisation of Eclampsia
NCT03856307Completed
Reliability of Simple Sonographic Findings Acquired With Hand-held Apparatuses to Inform Obstetric Diagnosis
NCT03674606Phase 4Completed
Trial of Early Screening Test for Pre-eclampsia and Growth Restriction
Showing all 5 trials